Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Minerva Endocrinol (2015) 40(2):12943
D.RustenhovenJ.ScotterE
indicated in the Competing interest section, the authors received no other funding for the manuscript preparation
PT-141 (Bremelanotide) The only FDA-approved peptide for hypoactive sexual desire disorder (HSDD) in premenopausal women, also used off-label in menopausal women
Bone-targeted nanocarriers functionalized with moieties that bind to hydroxyapatite, the primary mineral component of bone, have been developed to overcome these barriers ( Alendronate, a bisphosphonate with high affinity for bone mineral, has been widely used for bone-targeted drug delivery
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
